Isaac Benjamin Maresky, Chief Executive Officer at Vaxil Bio, holds 7.61M shares in Flow Beverage Corp. (Ticker: TSE:FLOW), holds 2.87M shares in Vaxil Bio (Ticker: TSE:VXL), holds 6.34M shares in BriaCell Therapeutics (Ticker: TSE:BCT). Most recently, Isaac Benjamin Maresky Bought ― shares of Flow Beverage Corp. on Mar 02, 2021 for an estimated value of 31.25K.
What is the percentage of profitable transactions made by Isaac Benjamin Maresky?
The percentage of profitable transactions made by Isaac Benjamin Maresky is 0%.
What is the average return per transaction made by Isaac Benjamin Maresky?
The average return per transaction made by Isaac Benjamin Maresky is -23.60%.
What stocks does Isaac Benjamin Maresky hold?
Isaac Benjamin Maresky holds: TSE:VXL, TSE:BCT, TSE:FLOW stocks.
What was Isaac Benjamin Maresky’s latest transaction?
Isaac Benjamin Maresky latest transaction was an Informative Buy of C$31.25K.
What was Isaac Benjamin Maresky's most profitable transaction?
Isaac Benjamin Maresky’s most profitable transaction was an Informative Buy of TSE:BCT stock on March 12, 2015. The return on the trade was 0.00%.
What is Isaac Benjamin Maresky's role in Vaxil Bio?
Isaac Benjamin Maresky's role in Vaxil Bio is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.